Many patients wonder if their current dose is sufficient for weight loss, especially when considering the clinical evidence showing dose-dependent outcomes across GLP-1 therapy
Phase 3 trials can fail, and regulatory timelines extend
Weight loss supplements do not need to be complicated or expensive, especially if they are naturally sourced with high-quality ingredients and bundled in a package that will maximize your results while saving you from excess costs
Semaglutide treatment was associated with marked weight loss, even during this relatively short trial
According to the Wegovy SmPC, gastrointestinal adverse reactions are frequently reported, with nausea (44%), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (10%) being most common in clinical trials
Not intended for injection, ingestion, or topical use